Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Buccal Tablet vs Oxycodone for Breakthrough Pain
NCT00813488Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough pain, sponsored by Cephalon, Inc.. Started Dec 2008; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00813488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813488.